← Back to Search

Behavioural Intervention

Lighting Intervention for Cancer-related Fatigue

N/A
Waitlist Available
Led By Sung Choi, MD
Research Sponsored by University of Michigan Rogel Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a light therapy delivered through a mobile app to help reduce fatigue in cancer patients. It targets those with breast cancer, prostate cancer, and those who have had stem cell transplants. The light helps reset the body's internal clock, improving sleep and reducing tiredness. Light therapy has been previously reported to improve cancer-related fatigue in cancer survivors.

Eligible Conditions
  • Breast Cancer
  • Prostate Cancer
  • Fatigue and Malaise
  • Blood Cancers
  • Fatigue
  • Survivorship

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in fatigue assessed with Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form (SF) Fatigue 4a
Secondary study objectives
Change in level of anxiety using PROMIS SF Anxiety 7a
Change in level of depression using PROMIS SF Depression 8a
Change in level of physical function using PROMIS SF Physical Function 8b
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention ArmExperimental Treatment3 Interventions
Light intervention delivered through SYNC app + blue-light blocking glasses.
Group II: Control ArmActive Control3 Interventions
Placebo light intervention delivered through SYNC app + clear glasses.

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,938 Previous Clinical Trials
41,023,031 Total Patients Enrolled
University of Michigan Rogel Cancer CenterLead Sponsor
300 Previous Clinical Trials
21,076 Total Patients Enrolled
Arcascope, IncUNKNOWN
Sung Choi, MDPrincipal InvestigatorUniversity of Michigan Rogel Cancer Center
1 Previous Clinical Trials
34 Total Patients Enrolled
~31 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top